InvestorsHub Logo
Followers 12
Posts 421
Boards Moderated 0
Alias Born 09/29/2010

Re: Murph1953 post# 5961

Monday, 11/10/2014 2:38:57 PM

Monday, November 10, 2014 2:38:57 PM

Post# of 27409
The doctors in Germany have cardiac surgery studies going on or planned including a 300-patient one with the University Hospital of Cologne that is currently enrolling patients. France is another market to develop to gain KOL support. The PR brings up that Cytosorb can be put into a heart-lung machine. The Sorin Group has the world's best selling heart-lung machine. It's a great partnership especially if the partnership can get CytoSorb used as a standard in cardiac surgery. I hope it is Sorin Group when the official PR confirming the partner' name comes out.

"About Sorin Group
Sorin Group is a global, medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,750 employees worldwide, Sorin Group focuses on two major therapeutic areas: Cardiac Surgery (cardiopulmonary products for open heart surgery and heart valve repair or replacement prostheses) and Cardiac Rhythm Management (pacemakers, defibrillators and noninvasive monitoring to diagnose arrhythmias and deliver anti-arrhythmia therapies as well as cardiac resynchronization devices for heart failure treatment). Every year, over one million patients are treated with Sorin Group devices in more than 100 countries."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News